In 2023, the global Artificial Urinary Sphincter Market is expected to be worth US$ 459.8 million. Artificial urinary sphincter sales are expected to grow at a 5.2% CAGR from 2023 to 2033, reaching US$ 760.5 million in 2033.
The artificial urinary sphincter industry is anticipated to expand as a result of an increase in the prevalence of urinary incontinence and the aging population. Healthcare facility improvements and technological breakthroughs may spur market expansion for artificial urinary sphincters.
Accelerate Your Journey to Excellence with Unmatched Efficiency! Claim Your Sample Now :
https://www.futuremarketinsights.com/reports/sample/rep-gb-5285
Revolutionizing Surgical Approaches: AUS Implantation and the Advantages of Minimally Invasive Procedures
A serious health problem affects millions of individuals. Urinary incontinence can significantly reduce a person’s quality of life. An implanted medical device called an AUS is used to treat urinary incontinence.
AUS mimics the action of the natural urinary sphincter by applying pressure to the urethra to prevent urine from leaking out of the bladder. Demand for AUS may be driven by the rising prevalence of urinary incontinence, particularly among old people.
Minimally invasive surgical approaches have gained popularity recently due to their many benefits over open surgery, such as short hospital stays, a low chance of problems, and speedy recovery times. Due to its effectiveness and safety, AUS implantation, a minimally invasive surgical procedure is becoming popular. The artificial urinary sphincter market growth may be fueled by the rising demand for minimally invasive surgical procedures.
The growing geriatric population is also anticipated to help market revenue growth. AUS may be required due to the prevalence of urinary incontinence, which is predicted to increase with population aging. It is anticipated that increasing healthcare spending and public awareness of cutting-edge medical technology may fuel the artificial urinary sphincter market further.
It is anticipated that the launch of technologically advanced AUS with improved efficacy and safety may contribute to the market expansion for artificial urinary sphincters.
Alternatives on the Horizon: Potential Limitations for Market Expansion
One important problem that could impede the market’s ability to grow in terms of revenue is the high cost of AUS implantation, which keeps many patients from being able to purchase the device. Further, the availability of alternate therapies, such as medication and pelvic floor exercises, is also anticipated to have an impact on the artificial urinary sphincter (AUS) market expansion.
Another factor that could prevent the industry from generating income is the rigorous regulatory environment, which may delay product approvals and market launches.
Curious? We’ve Got Answers! Unleash Your Questions and Uncover the Knowledge You Seek – Ask Us Anything Today :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5285
Regional Outlook
In North America, the leading revenue share in the artificial urinary sphincter market is projected during the forecast period. The region’s high demand for artificial urinary sphincters is primarily driven by the increasing prevalence of urinary incontinence, contributing to revenue growth. Also, the utilization of innovative medical technology and the availability of attractive reimbursement guidelines for urinary incontinence treatments support the artificial urinary sphincter market expansion.
Europe is to hold a considerable revenue share in the artificial urinary sphincter (AUS) market. This development can be attributed to an aging population, which is susceptible to urinary incontinence, and the growing awareness of innovative treatment alternatives for the condition. Further, the presence of significant artificial urinary sphincter manufacturers and increased investments in research and development activities are expected to surge revenue growth.
Asia Pacific’s artificial urinary sphincter (AUS) market is poised to achieve increasing revenue compound annual growth rate (CAGR) during the forecast period. The region, especially in developing countries witness a rising prevalence of urinary incontinence, contributing to AUS market growth. Moreover, increased awareness about improved treatment options and investments in healthcare infrastructure are expected to propel artificial urinary sphincter (AUS) market growth.
Key Takeaways :
- The hospital segment in the end user category is estimated to grab a share of 66.30% from 2023 to 2033.
- In the gender category, the male segment is predicted to acquire a market share of 78.20% between 2023 and 2033.
- The United States artificial urinary sphincter business is likely to acquire a share of 31.1% by 2023.
- Germany’s artificial urinary sphincter industry is estimated to secure a share of 6.3% by 2023.
- Japan’s artificial urinary sphincter market is likely to hold a share of 4.9% by 2023.
- Australia’s artificial urinary sphincter (AUS) market is to develop at a CAGR of 4.6% by 2023.
- China’s artificial urinary sphincter business is expected to thrive at a CAGR of 6.3% through 2033.
- India’s artificial urinary sphincter industry is anticipated to capture a CAGR of 5.2% from 2023 to 2033.
- The United Kingdom artificial urinary sphincter (AUS) market is predicted to evolve at a CAGR of 3.6% through 2033.
- North America’s artificial urinary sphincter industry is to grab a share of 34.8% by 2023.
- Europe AUS market is to hold a share of 25.8% by 2023.
Competitive Landscape
The competition in the artificial urinary sphincter market is intense, with several established players vying for market share. Companies are engaged in continuous research and development efforts to introduce technologically advanced and cost-effective products.
Also, strategic partnerships and collaborations are common strategies employed to strengthen market position and expand global reach.
Novel Breakthrough
- Boston Scientific’s AMS 800 urinary control system is designed specifically for male SUI. A little over 150,000 people have been treated with AMS 800 after being affected by SUI, according to data provided by Boston Scientific Corporation.
Key Players Operating in the Global Market
- Boston Scientific Corporation
- RBM – Reinhard Becker Medizinprodukte
- ZSI
- Zephyr Surgical Implants
- Silimed Medical Devices
- Albyn Medical
- GT Urological LLC
- Promedon
- UroMems Inc.
- Uromedica Inc.
- My powers Medical
- CooperSurgical Inc.
- Laborie Medical Technologies Inc.
Insights Designed for You: Customize Your Exclusive Report Today :
https://www.futuremarketinsights.com/customization-available/rep-gb-5285
Key Segmentation
By End User:
- Hospitals
- Clinics
- Academic and Research Institutes
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube